Metropolitan Life Insurance Company (MetLife)’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,630
| Closed | -$4.63K | – | 1481 |
|
|
2024
Q1 | $4.63K | Sell |
1,630
-2,331
| -59% | -$6.62K | ﹤0.01% | 2250 |
|
|
2023
Q4 | $16.2K | Hold |
3,961
| – | – | ﹤0.01% | 2004 |
|
|
2023
Q3 | $12.6K | Hold |
3,961
| – | – | ﹤0.01% | 2113 |
|
|
2023
Q2 | $13.2K | Buy |
+3,961
| New | +$13.2K | ﹤0.01% | 2150 |
|
|
2023
Q1 | – | Sell |
-4,331
| Closed | -$11.7K | – | 2422 |
|
|
2022
Q4 | $11.7K | Hold |
4,331
| – | – | ﹤0.01% | 2236 |
|
|
2022
Q3 | $14K | Buy |
4,331
+1,800
| +71% | +$5.83K | ﹤0.01% | 2182 |
|
|
2022
Q2 | $12.4K | Sell |
2,531
-2,113
| -45% | -$10.3K | ﹤0.01% | 2260 |
|
|
2022
Q1 | $35.4K | Sell |
4,644
-6,122
| -57% | -$46.6K | ﹤0.01% | 1789 |
|
|
2021
Q4 | $99.5K | Sell |
10,766
-514
| -5% | -$4.75K | ﹤0.01% | 2487 |
|
|
2021
Q3 | $161K | Buy |
+11,280
| New | +$161K | ﹤0.01% | 2247 |
|
|
2021
Q2 | – | Sell |
-7,752
| Closed | -$141K | – | 2828 |
|
|
2021
Q1 | $141K | Buy |
+7,752
| New | +$141K | ﹤0.01% | 2248 |
|